SAFEGUARDING THERAPEUTICS ACT; Congressional Record Vol. 166, No. 165
(Extensions of Remarks - September 23, 2020)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Extensions of Remarks]
[Page E875]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                     SAFEGUARDING THERAPEUTICS ACT

                                 ______
                                 

                               speech of

                           HON. ANNA G. ESHOO

                             of california

                    in the house of representatives

                       Monday, September 21, 2020

  Ms ESHOO. Madam Speaker, I rise in support of H.R. 5663, the 
Safeguarding Therapeutics Act. I'm proud to have advanced this 
bipartisan bill through my Health Subcommittee and I'm pleased to 
support it on the Floor.
  The Safeguarding Therapeutics Act was introduced by Representatives 
Brett Guthrie and Eliot Engel.
  Today, the FDA has the authority to destroy confiscated counterfeit 
or adulterated drugs. This bill extends that authority to medical 
devices.
  Illicit trade and counterfeit products present growing risks to 
patients and consumers. We have the opportunity to ensure that FDA has 
the authority needed to destroy counterfeit drugs, devices and 
combination products.
  This bill closes a gap and protects patients from the growing threat 
of counterfeit products, and I urge my colleagues to support this 
legislation.

                          ____________________